Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

EvogeneLtd. Company Profile (NASDAQ:EVGN)

Consensus Ratings for EvogeneLtd. (NASDAQ:EVGN) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $24.33 (82.14% upside)

Analysts' Ratings History for EvogeneLtd. (NASDAQ:EVGN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/17/2013Deutsche BankInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013OppenheimerInitiated CoverageOutperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013Piper JaffrayInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
12/16/2013Credit SuisseInitiated CoverageOutperform$25.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/22/2012 forward)
Discuss EvogeneLtd.